Local Control in Childhood Extremity Sarcomas: Salvaging Limbs and Sparing Function

Medical and Pediatric Oncology

Volumn 41, Issue 6, 2003, Pages 584-587

  Rao, Bhaskar N ^a   Rodriguez Galindo, Carlos ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; PLATINUM DERIVATIVE;

AMPUTATION; ANGIOMATOID MALIGNANT FIBROUS HISTIOCYTOMA; ANGIOSARCOMA; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER CONTROL; CANCER GRADING; CANCER INVASION; CHILD; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG MEGADOSE; DYNAMIC ENHANCED MAGNETIC RESONANCE IMAGING; EPITHELIOID SARCOMA; EWING SARCOMA; HUMAN; INFANTILE FIBROSARCOMA; INFANTILE HEMANGIOPERICYTOMA; LIMB SALVAGE; LYMPH NODE BIOPSY; MULTIMODALITY CANCER THERAPY; NON INVASIVE MEASUREMENT; NON RHABDOMYOSARCOMA SOFT TISSUE SARCOMA; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHESIS; RADIATION DOSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; SARCOMA; SECOND LOOK SURGERY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; TREATMENT FAILURE;

ARM; BONE NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; HUMANS; LEG; NEOPLASM STAGING; OSTEOSARCOMA; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RHABDOMYOSARCOMA; SARCOMA; SARCOMA, EWING'S;

EID: 0242658958     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.10405     Document Type: Note

References (24)

1. Marcove RC, Mike V, Hajek JV, et al. Osteogenic sarcoma under the age of twenty-one. A review of one-hundred and forty-five operative cases. J Bone Joint Surg Am 1970;52:411-423.
2. Rosen G, Nirenberg A. Chemotherapy for osteogenic sarcoma: An investigative method, not a recipe. Cancer Treat Rep 1982;66: 1687-1697.
3. Meyers PA, Gorlick R, Heller G, et al. Intensification of preoperative chemotherapy for osteogenic sarcoma: Results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol 1998; 16:2452-2458.
4. Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: The Memorial Sloan-Kettering Experience. J Clin Oncol 1992;10:5-15.
5. Fuchs N, Bielack SS, Epler D, et al. Long-term results of the cooperative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998;9:893-899.
6. Bacci G, Ferrari S, Lari S, et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br 2002;84:88-92.
7. Bielack SS, Kempf-Bielack B, Delling G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group Protocols. J Clin Oncol 2002;20:776-790.
8. Reddick WE, Wang S, Xiong X, et al. Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer 2001;91:2230-2237.
9. Bacci G, Ferrari S, Mercuri M, et al. Predictive factors for local recurrence in osteosarcoma. 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand 1998;69:230-236.
10. Picci P, Sangiorgi L, Rougraff BT, et al. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 1994;12:2699-2705.
11. Cool WP, Carter SR, Grimer RJ, et al. Growth after extendible endoprosthetic replacement of the distal femur. J Bone Joint Surg Br 1997;79:938-942.
12. Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors: A subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994;331:294-299.
13. Hill DA, O'Sullivan MJ, Zhu X, et al. Practical application of molecular genetic testing as an aid to the surgical pathologic diagnosis of sarcomas: A prospective study. Am J Surg Pathol 2002;26:965-977.
14. Rodriguez-Galindo C, Spunt SL, Pappo AS. Treatment of Ewing sarcoma family of tumors: Current status and outlook for the future. Med Pediatr Oncol 2003;40:276-287.
15. Raney RB, Anderson JR, Barr FG, et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: A selective review of Intergroup Rhabdomyosarcoma Study Group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 2001;23:215-220.
16. Sorensen PHB, Lynch JC, Qualman SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolas rhabdomyosarcoma: A report from the Children's Oncology Group. J Clin Oncol 2002;20:2672-2679.
17. Kaste SC, Hill A, Conley L, et al. Magnetic resonance imaging after incomplete resection of soft tissue sarcoma. Clin Orthop 2002;397: 204-211.
18. Rao BN. Nonrhabdomyosarcoma in children: Prognostic factors influencing survival. Semin Surg Oncol 1993;9:524-531.
19. Spunt SL, Poquette CA, Hurt YS, et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: An analysis of 121 patients treated at St. Jude Children's Research Hospital. J Clin Oncol 1999;17: 3697-3705.
20. Spunt SL, Hill DA, Motosue AM, et al. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Clin Oncol 2002;20:3225-3235.
21. Rodriguez-Galindo C, Ramsey K, Jenkins JJ, et al. Hemangiopericytoma in children and infants. Cancer 2000;88:198-204.
22. Chui CH, Spunt SL, Liu T, et al. Is reexcision in pediatric nonrhabdomyosarcoma soft tissue sarcoma necessary after an initial unplanned resection? J Pediatr Surg 2002;37:1424-1429.
23. Blakely ML, Spurbeck WW, Pappo AS, et al. The impact of margin of resection on outcome in pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Pediatr Surg 1999;34:672-675.
24. Merchant TE, Parsh N, Lezama del Valle P, et al. Brachytherapy for pediatric soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 2000;46:427-432.